RecruitingNot ApplicableNCT06560294
Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome
Glue Embolization Versus Conservative Treatment for Pelvic Congestion Syndrome: A Randomized Trial
Sponsor
Tanta University
Enrollment
40 participants
Start Date
Aug 17, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.
Eligibility
Sex: FEMALEMin Age: 30 YearsMax Age: 50 Years
Inclusion Criteria2
- Women aged from 30 to 50 years.
- Complaining from pelvic congestion syndrome.
Exclusion Criteria6
- Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
- Patients who are treated with opiates to reduce pelvic pain in the period before the study.
- Patient with history of contrast allergy
- Patient with renal impairment
- Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst
- Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGMicronized purified flavonoid fraction (Daflon ®)
Patients will receive micronized purified flavonoid fraction (Daflon ®), 500 mg twice/daily for 3 months.
OTHERGlue embolization
Patients will receive transcatheter glue embolization.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06560294